Get the latest crypto news, updates, and reports by subscribing to our free newsletter.
Giấy phép số 4978/GP-TTĐT do Sở Thông tin và Truyền thông Hà Nội cấp ngày 14 tháng 10 năm 2019 / Giấy phép SĐ, BS GP ICP số 2107/GP-TTĐT do Sở TTTT Hà Nội cấp ngày 13/7/2022.
© 2026 Index.vn
The DJS Law Group has reminded investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (“Inovio” or “the Company”) (NASDAQ: INO) alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, as promulgated by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to participate in any recovery.
Class period: October 10, 2023 to December 26, 2025
Deadline: April 7, 2026
According to the complaint, the lawsuit alleges that the company made false and misleading statements to the market. The complaint further alleges that manufacturing deficiencies with Inovio’s CELLECTRA device were likely to cause delays in its filing of a BLA with the FDA, and that the company did not gather evidence necessary to support a priority review by the FDA. Based on these facts, the complaint alleges that Inovio’s public statements were false and materially misleading throughout the class period.
The firm states that investors who suffered losses may contact it to participate in the action.
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…